Combination of histone deacetylase inhibitors with chemotherapeutic agents

Details for Australian Patent Application No. 2004241729 (hide)

Owner Novartis AG

Inventors Atadja, Peter Wisdom; Trogani, Nancy; Remiszewski, Stacy William

Agent Davies Collison Cave

Pub. Number AU-A-2004241729

PCT Pub. Number WO2004/103358

Priority 60/472,161 21.05.03 US

Filing date 19 May 2004

Wipo publication date 2 December 2004

International Classifications

A61K 031/16 - Amides, e.g. hydroxamic acids

A61K 031/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 031/4745

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/4045

A61P 035/04 Antineoplastic agents

A61K 031/704

A61K 031/7068

A61P 035/00 Antineoplastic agents

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/103358 Priority application(s): WO2004/103358

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004241736-Chromatography column with movable adapter

2004241722-Fungicidal mixtures